Abiopharma

🔍 Wolfe Kristin (Executive)

Company: Burlington Stores, Inc. (BURL)

Report Date: 2026-06-17

Detailed Transactions and Holdings:

• Acquired 3,768 shares of Common Stock at $150.17 per share (Direct)
  Date: 2026-06-17 | Code: M | equity_swap_involved: false | shares_owned_after: 33,592.00 | transaction_form_type: 4
• Acquired 1,500 shares of Common Stock at $150.17 per share (Direct)
  Date: 2026-06-17 | Code: M | equity_swap_involved: false | shares_owned_after: 35,092.00 | transaction_form_type: 4
• Sold 2,930 shares of Common Stock at $339.1 per share (Direct)
  Date: 2026-06-17 | Code: S | equity_swap_involved: false | shares_owned_after: 32,162.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,060 shares of Common Stock at $340.34 per share (Direct)
  Date: 2026-06-17 | Code: S | equity_swap_involved: false | shares_owned_after: 30,102.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 3,210 shares of Common Stock at $341.1 per share (Direct)
  Date: 2026-06-17 | Code: S | equity_swap_involved: false | shares_owned_after: 26,892.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 3,768 shares of Employee Stock Option (right to buy) at $150.17 per share (Derivative)
  Date: 2026-06-17 | Code: M | Expires: 2032-08-01 | equity_swap_involved: false | shares_owned_after: 1,257.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 1,500 shares of Employee Stock Option (right to buy) at $150.17 per share (Derivative)
  Date: 2026-06-17 | Code: M | Expires: 2032-08-01 | equity_swap_involved: false | shares_owned_after: 30,314.00 | transaction_form_type: 4 | Footnotes: F5

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $338.72 to $339.68. The reporting person undertakes to provide to Burlington Stores, Inc., any security holder of Burlington Stores, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $339.86 to $340.72. The reporting person undertakes to provide to Burlington Stores, Inc., any security holder of Burlington Stores, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $340.93 to $341.43. The reporting person undertakes to provide to Burlington Stores, Inc., any security holder of Burlington Stores, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
• F4: The options are exercisable as to 75% of the shares. The remaining 1,257 shares are scheduled to vest on August 1, 2026.
• F5: The options are exercisable as to 100% of the shares.